Correlation Between Rigel Pharmaceuticals and HAVN Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and HAVN Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and HAVN Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and HAVN Life Sciences, you can compare the effects of market volatilities on Rigel Pharmaceuticals and HAVN Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of HAVN Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and HAVN Life.

Diversification Opportunities for Rigel Pharmaceuticals and HAVN Life

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Rigel and HAVN is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and HAVN Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HAVN Life Sciences and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with HAVN Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HAVN Life Sciences has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and HAVN Life go up and down completely randomly.

Pair Corralation between Rigel Pharmaceuticals and HAVN Life

Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 16.81 times less return on investment than HAVN Life. But when comparing it to its historical volatility, Rigel Pharmaceuticals is 10.97 times less risky than HAVN Life. It trades about 0.06 of its potential returns per unit of risk. HAVN Life Sciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  5.00  in HAVN Life Sciences on September 2, 2024 and sell it today you would lose (4.48) from holding HAVN Life Sciences or give up 89.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.8%
ValuesDaily Returns

Rigel Pharmaceuticals  vs.  HAVN Life Sciences

 Performance 
       Timeline  
Rigel Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
HAVN Life Sciences 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HAVN Life Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting essential indicators, HAVN Life reported solid returns over the last few months and may actually be approaching a breakup point.

Rigel Pharmaceuticals and HAVN Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rigel Pharmaceuticals and HAVN Life

The main advantage of trading using opposite Rigel Pharmaceuticals and HAVN Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, HAVN Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HAVN Life will offset losses from the drop in HAVN Life's long position.
The idea behind Rigel Pharmaceuticals and HAVN Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity